ABSTRACT
INTRODUCTION
PCOS is a complex endocrinemetabolic disorder characterized by chronic anovulation and/or clinical/ biochemical hyperandrogenism and/or polycystic ovaries at ultrasonography
(1) . It is an endocrinological disorders affecting 6-10% of females of reproductive age (2,3) . IR is a common feature of PCOS and is more in obese women, suggesting that PCOS and obesity have a synergistic effect on the magnitude of the insulin disorder. It leads to increased insulin secretion by beta-cells and compensatory hyperinsulinemia (4) . IR in PCOS was considered a risk factor for gestational diabetes (5) . Moreover, If beta-cell compensatory response declines, relative or absolute insulin insufficiency develops which may lead to glucose intolerance and type 2 diabetes (6) . On the basis of the theory that IR and hyperinsulinemia may be a relevant contributor to the pathophysiology of PCOS, it has been hypothesized that insulin-lowering agents (metformin), by reducing hyperinsulinemia, might improve the metabolic and reproductive abnormalities of PCOS (7, 8) . Nevertheless, the mechanisms underlying the beneficial effects of metformin in the treatment of PCOS remain debated (9) . Besides, laparoscopic ovarian drilling was found to have significant reproductive and metabolic effects in women with hyperinsulinemia (10) . This study aimed to clarify the pathophysiological mechanisms of PCOS and highlight on the basic relationship between it and IR and to investigate the efficacy of metformin therapy and ovarian drilling in women with PCOS and insulin resistance.
PATIENTS & METHODS

Study population:
Thirty two PCOS patients with age ranged between 22-35 years (16 patients received metformin 850 mg twice daily for four months (according to Trolle et al. (11) , group 1, and(16 underwent laparoscopic ovarian drilling, group 2, (4-8 punctures, each for 4 seconds according to ovarian volume) using monopolar diathermy (adjusted to 40-60 watt) , were included in the study. Patients were resistant to Clomiphene citrate (selective estrogen receptor modulator used mainly in female infertility due to anovulation) and they were recruited from Gynecology (Figure 2 a, b and c) : In OGTT, PCOS patients had impaired fasting glucose (110-126 mg/dl) at baseline when compared with controls ( Fig. 2 a) . Administration of metformin in group (1) and laparoscopic ovarian drilling in group (2) significantly lowered the blood glucose level compared with pretreatment values 3. 4. Effect of metformin and ovarian drilling on metabolic and reproductive parameters in PCOS patients ( Table 2) : Administration of metformin significantly decreased BMI, serum T, LH levels, IGF-1 and AFC (P≤ 0.001) and increased the G/I ratio (P≤0.001) compared with pretreatment values. In addition, ovarian drilling significantly decreased serum T and AFC, IGF-1 (P≤ 0.001) and LH levels ((P≤ 0.01), significant increase G/I ratio (P≤ 0.05) and had no significant effect on BMI compared with preoperative values. 
insulin (uIU/ ml) F. G/I ratio AFC
28. 6 ± 2.6 23.5 ± 2.2 42.5 ± 8.7 5.6 ± 1.2 118 ± 29.5 86 ± 11.3 12 ± 3.2 7.53 ± 0.8 8.2 ± 2.4 29.3 ± 4.5 NS 36.2 ± 3.4 *** 97.6 ± 15.2 *** 15.2 ± 2.6 *** 187 ± 35.6*** 119 ± 20.2*** 35.5 ± 12.6*** 3.51 ± 0.6*** 33.9 ± 11.85*** NS: Non Significant, *** P ≤ 0. 
DISCUSSION
Insulin resistance is defined as the inability of insulin to exert its physiological effect. It is manifested peripherally (at the tissues) or centrally (at the liver) through reduction in the ability of insulin to lower plasma glucose (17) . The pathophysiology of PCOS is still largely unknown and until now, medical care of these subjects has been limited to symptomatic control and infertility (18) . While the basic pathophysiological mechanisms seem to be caused by dysfunction of the ovary, the clinical expression and severity of the symptoms are dependent on extra ovarian factors. Our knowledge about the actual mechanisms of PCOS and its relation to IR is indistinct. In this study, we hypothesized that IR and the associated hyperinsulinemia may play a key role in the pathophysiology of this syndrome.
Clinical evaluation of patients in the present study revealed increased BMI compared with controls that harmonized with previous investigators who report that obesity could be found in 10-50% of women with PCOS who are having BMI outside the acceptable rang of 19-25 kg/m² (17) . Obesity (the fat mass), body fat location and muscle mass all have important independent effect on insulin sensitivity. Alterations in these parameters could potentially contribute to insulin resistance in PCOS in a number of ways.
In particular, several metabolites (such as free fatty acid and lactate) as well as tumor necrosis factor-1 and leptin, whose production rates increases in obesity state, directly affect the peripheral action of insulin (impair insulin-mediated glucose uptake in skeletal muscle, adipocytes and liver and decrease hepatic insulin sensitivity and increase hepatic glucose output) (19-21) . Significant higher fasting insulin and glucose levels with decreased fasting G/I ratio were observed in PCOS patients of this study when compared with control value. These results are in accordance with previous studies which reported that hyperinsulinemia due to insulin resistance occurs in the majority of women with PCOS (22,23) . This is thought to be due to decreased insulin sensitivity with post-receptor defect (reduced autophosphorylation of insulin receptor in the ovary) with decreasing insulin -stimulated glucose uptake (3) . In women with PCOS, basal insulin secretion is increased and hepatic insulin clearance is reduced, resulting in hyperinsulinemia. Insulinstimulated glucose utilization is decreased by 35-40% in women with PCOS, therefore blood glucose levels become raised, a phenomenon known as hyperglycemia (24, 25) . Under normal circumstances, insulin secretion increases as insulin sensitivity decreases, in order to maintain glucose homeostasis. This relationship of insulin sensitivity and insulin secretion known as the deposition index that described by Pasquali et al.
(26) . In OGTT, blood glucose levels were proved to be significantly higher in PCOS patients in the existing investigation than control group and when fasting glucose levels were analyzed according to the recommendations of the Expert Commitiee of the American Diabetes Association (14) , we found that most of PCOS patients had impaired fasting glucose (≥110 mg/dl and <126 mg/dl). These results indicated the high prevalence of glucose intolerance in PCOS women, and these patients are at increased risk of developing non insulin dependent diabetes mellitus (NIDDM) that harmonized with other previous studies (26-28) . A significant negative correlation between BMI and fasting G/I ratio. This could support the possibility that obesity in women with PCOS can exacerbate insulin resistance and enhance the risk of NIDDM which is accounted in this study by the high prevalence of impaired oral glucose tolerance test
In the current study, PCOS patients showed significant higher levels of total testosterone, LH and IGF-1 compared with controls. Also in PCOS women, it was found that total testosterone is negatively correlated with fasting glucose/insulin ratio which means that the higher the insulin, the higher the androgen level suggesting a possible causal relationship. The pathophysiological mechanisms of hyperandrogenemia found in this study could be explained by that high circulating insulin levels resulting from insulin resistance stimulate ovarian theca cell androgen production both by a direct action on the ovary (through binding to insulin or IGF-1 receptors) and by stimulating the release of LH. Hyperinsulinemia may also enhance the bioavailability of androgen by decreasing the biosynthesis of IGF-binding protein-1 thus elevating IGF-1 levels which like insulin stimulates ovarian androgen production.
In turn, hyperandrogenemia may increase insulin resistance in adipose tissues and skeletal muscle, resulting in a vicious circle of increasing androgen levels and worsening insulin resistance (29, 30) . These data support the hypothesis that insulin resistance could play a role in the pathophysiology of reproductive abnormalities characteristic of PCOS.
In the present study, ultrasound examination of the ovaries revealed significantly higher number of antral follicle in the patients group versus controls. These follicles are arrested in development at a size of 2-9 mm, with enlarged stromal volume >10 cc. It is suggested that excess androgens probably play a key role in the etiology of this abnormal ovarian morphology as evident by increasing levels of testosterone in PCOS patients of this study. Androgens encourage the development of primary follicles to the stages of pre-antral and small antral follicles and in the presence of excess androgen; this process is accelerated compared with normal ovary. In addition, several factors that inhibit the endogenous action of Follicle Stimulating hormone(FSH) such as follistatin, epidermal growth factor and a number of anti-apoptotic factors lead to arrest of further follicular growth and slow down the turn over of these arrested follicles. All these factors combine to give the characteristic polycystic ovarian morphology (31) . In accordance with Bayrak et al.
(15) data of the current study showed a significant negative correlation between G/I ratio and AFC which support that insulin resistance and hyperandrogenism have a significant impact on polycystic ovarian morphology. Further, it was reported that insulin resistance is more severe in women with PCOS who are an-ovulatory than in those who are equally hyperandrogedemic but have normal cycles. This suggests that insulin resistance contributes to anovulation (32) . Perhaps, the most convincing evidence linking insulin resistance with reproductive and metabolic abnormalities in women with PCOS is the utilization of insulin-sensitizing drug (metformin) to restore ovulation and metabolic disorders. Therefore, in the present study, metformin therapy improved the measured parameters of IR demonstrated by significant increase G/I ratio and significant decrease total testosterone level, LH, IGF-1, AFC and BMI compared with pretreatment values. These results are in accordance with many studies (33-35) . It was reported that metformin reduce insulin resistance and insulin secretion followed by a reduction of ovarian androgen production. Also, a direct action of metformin on ovarian theca cells to reduce androgen production was also postulated (36,37,9) . Improved IR by metformin may not only result from the well-known reduction of hepatic glucose production and increase of peripheral glucose utilization but also from a direct effect on ovarian steroidogenesis, as demonstrated by in vitro studies of Tosca et al.
(38) . Pasquali et al.
(26) found that metformin effects occur without significant action on beta-cell insulin production but may be reduced insulin response to an oral glucose load (39) . The significant decrease in AFC observed in this study following metformin treatment was in agreement with Bayrak et al.
(15) , however whether this effect was due to an improvement in IR is unclear, but plausible. It is also, observed that metformin as a mono-agent was capable of improving menstrual frequency and restoring ovulation in PCOS patients who have oligo/anovulation (40,41) . Therefore, this dose of metformin may be sufficient to achieve improvements in the biochemical markers and polycystic ovarian morphology as evident by our study. On the other hand, other studies that assessed metformin effects in hyperandrogenic subjects did not confirm these findings (18) . Laparoscopic ovarian drilling had been selected to induce ovulation in PCOS women. Although the effectiveness of bilateral ovarian wedge resection had been established, laparoscopic ovarian drilling with diathermy or LASER had been recognized as more useful because of their lower invasiveness and decrease risk of adhesions (7) . In the present work, it was found that both AFC and testosterone, LH and IGF-1 levels significantly decreased also blood glucose levels (in oral glucose tolerance test) slightly decreased and fasting G/I ratio was slightly increased but the BMI was non significantly changed in PCOS patients following ovarian drilling compared with pretreatment values. These results agreed with the report conducted by Youssef and Atallah (42) and Badawy et al.
(43) who found that in women with PCOS following ovarian drilling, there was significant improvement of ovulation and pregnancy associated with decreasing serum LH and testosterone levels but not FSH or LH / FSH ratio. Therefore, the present data observed after ovarian drilling are of considerable interest, however they need further study to clear their detail mechanisms involved. 
CONCLUSION
